phrma news from FierceHealthcare
News
Health lobbying explodes in 2009
We all know that the Hill has been thick with lobbyists since reform debates began in earnest this year. Just how thick? Well, according to a new analysis appearing in USA Today, the number of... Read more...
Coming into the home stretch, pharma spends big on lobbying
With health reform set for one of the biggest remakes in U.S. history, it's little wonder that health players are spending big bucks on lobbying Capitol Hill. But of all the moneyed healthcare... Read more...
Harry and Louise are back--and pitching health reform
If you have a grey hair or two on your head, you doubtless remember Harry and Louise, the hapless middle-class couple depicted in 1990s anti-reform ads mounted by health insurance industry. Harry and... Read more...
VT wins battle to bar marketing use of Rx data
Vermont has won an important battle in its war to block the use of prescriber-identifiable data for drug marketing. A law instituting such a block had been challenged by a group of prescription... Read more...
Pharma trade group says it's part of the solution
I don't know if I buy it, but they're certainly trying to sell it. Drug company trade group PhRMA is making the rounds in Washington, vowing that it will be "part of the solution" when it comes to... Read more...
Senators file bill requiring disclosure of MD gifts above $100 per year
Sens. Chuck Grassley (R-IA) and Herb Kohl (D-WI) have filed a bill requiring pharmas and medical device firms to publicly disclose either gifts or payments valued at $100 or more once per calendar... Read more...
Congress keeps heat on DTC advertising
Direct-to-consumer pharmaceutical advertising is coming under more heavy fire from Congress, despite efforts by drugmakers to hold off regulation of one of their favorite marketing channels. This... Read more...
MA drops planned ban on physician gifts from drugmakers
Massachusetts legislators have stripped several controversial provisions out of pending legislation which would have imposed strict new rules on pharmaceutical company relationships with doctors. ... Read more...
